|
JBJS welcomes reader comments on published articles. Letters to the Editor are reviewed by JBJS editors but are not peer-reviewed. To submit your letter, please follow the "submit a response" link that appears in the content box at the upper right of the full text of the article.
Letters to the Editor to:
-
- Editorials:
Bertram Zarins
- Are Validated Questionnaires Valid?
J Bone Joint Surg Am 2005; 87: 1671-1672
[Full text]
[PDF]
|
|
Electronic letters published:
-
Perspective Bias
- John E. Kuhn
(21 November 2005)
-
Counterpoint to “Are Validated Questionnaires Valid?”
- Frederick A. Matsen, M.D., Edward V. Fehringer, M.D.
(25 October 2005)
-
Dr.Zarins responds to Drs. Anderson and Irrgang
- Bertram Zarins, M.D., Consulting Editor for Sports Medicine, JBJS
(25 October 2005)
-
Are Validated Questionnaires Valid?
- Allen F. Anderson, M.D., James J. Irrgang, Ph.D., PT, ATC
(25 October 2005)
-
Are Validated Questionnaires Valid?
- Bruce D. Beynnon, Ewa Roos, Stefan Lohmander, and Robert J Johnson
(29 September 2005)
-
Are Validated Questionnaires Valid?
- James G. Wright, M.D.
(21 September 2005)
|
Perspective Bias |
21 November 2005 |
|
|
John E. Kuhn, Chief of Shoulder Surgery Vanderbilt University Medical Center, Nashville, TN 37212
Send letter to journal:
Re: Perspective Bias
j.kuhn{at}vanderbilt.edu John E. Kuhn
|
To The Editor:
I read with interest the editorial by Zarins titled ““Are validated
questionnaires valid?”
Dr. Zarins makes clear his preference for “objective”
measures of outcome, and shows his disdain for “subjective
questionnaires”. Unfortunately, Dr. Zarins suffers from a bias in
perspective.
A patient presents with symptoms of knee instability, which prevent that
individual from playing in his or her sport. The surgeon identifies a
tear of the ACL as the source of the patient’s concerns. The patient
seeks treatment to be able to play on a stable, pain-free knee. The
surgeon will operate to restore ACL integrity. These are very different
perspectives of the same problem. The outcome of treatment can be
approached from either perspective. Which outcome is more important? It
depends on the question you are asking.
If you are interested in the
clinical outcome of a treatment, then clearly the patient’s perspective is
most important. The KT-1000 can not tell us that the patient is playing
without pain and without episodes of giving way. Only validated
subjective questionnaires can answer this question. If you are interested
in a new ACL graft option, or comparing your surgical method to a normal
knee then the KT-1000 can tell us if there is a difference in anterior
laxity in 30 degrees of knee flexion. Just as the KT-1000 cannot tell us
is a patient returns to sport, the validated questionnaire cannot tell us
if the surgery was successful in correcting laxity with the knee at 30
degrees of flexion. Every measurment tool has potential for bias and
error, and both subjective and objective measures can be valid.
The real
issue is what is the question driving the research effort, and then did
the authors use the best tool to measure the outcome in question? As
surgeons we must remove out blinders, stop thinking about patients as
their pathology, and welcome patient-oriented measures of outcome. |
|
Counterpoint to “Are Validated Questionnaires Valid?” |
25 October 2005 |
|
|
Frederick A. Matsen, M.D., Orthopaedic surgeon University of Washington, Seattle, WA 98195, Edward V. Fehringer, M.D.
Send letter to journal:
Re: Counterpoint to “Are Validated Questionnaires Valid?”
matsen{at}u.washington.edu Frederick A. Matsen, M.D., et al.
|
To The Editor:
In the August 2005 volume of the Journal, my respected colleague,
Bert
Zarins, wrote a provocative piece with the title quoted above. While what
he
says rings true, there are other aspects to the “validity” issue that
should be
added to our thoughtful consideration. I will enlist the help of another
Massachusetts General surgeon who is often, but incompletely, quoted:
“Already in 1900 I had become interested in what I have called the
End Result
Idea, which was merely the common-sense notion that every hospital should
follow every patient it treats, long enough to determine whether or not
the
treatment has been successful, and then to inquire ‘if not, why not?’” “We
had
found that this routine tracing of every case, interesting or
uninteresting, had
brought to our notice many things in which our knowledge, our technique,
our organization, our own skill or wisdom, and perhaps even our care and
our
consciences, needed attention.” When he presented this idea in 1913 in the
great hall of the Philadelphia Academy of Medicine, Codman pointed out
that
answering these questions is of primary interest to the patient, the
public,
and the medical field. He then asked, “Who represents or acts for these
interests” and answered “Strangely enough the answer is: No one.” In his
infamous cartoon of the Back Bay Golden Goose Ostrich, he showed the bird
producing golden eggs of profit while hiding her head in the sand so she
could not see how much (or how little) the care was benefiting the
patient.
(1). For his insolence he was fired from the hospital.
A century later we are struggling with the same issues.
If we are to have a valid assessment of the effectiveness of an
operation, we
first need a method for determining the result in a reasonable statistical
sample of patients having this procedure. As an example of the difficulty
in
achieving this objective, Hassan and others have shown that the great
majority of shoulder arthroplasties are done by surgeons who perform fewer
than four per year (2). Because these common cases are not
included in studies of outcomes, the surgical results data published in
the
peer reviewed literature are not particularly relevant, because they lack
common external validity – that is, they cannot be applied to the common
surgical experience. We are surely a long way from complying with Codman’s notion of following “every” patient. The issue is that, as he pointed out,
no
one is representing or acting in the interest of the average patient
having the
surgery.
The two key steps in helping us get valid data on the common
experience are to apply the simplest effective tool for measuring the result of
treatment
(such as a series of ‘yes or no’ questions about comfort and function that
the
patient can complete before and sequentially after their procedure); and
to
exert leadership at all levels for the broad collection and analysis of
these
data. The argument for the most practical metrics for this purpose must be
made forcefully to balance the views expressed by Dr. Zarins that more
costly
“objective measures, such as physical examination findings, radiographs,
and
arthrometer measurements" are required for validity. The impracticality of
rigorously applying these “objective measures” in common practice
systematically and selectively excludes the largest and most important
groups of patients and surgeons from the sample, those in general
orthopaedic practices.
As the expense of medicine becomes progressively unaffordable, the
need for
externally valid, generalizable analyses of surgical effectiveness will be
pressed on us by the employers, who are responsible for the medical
benefits
of their employees, and by the government, which is responsible for the
medical benefits of those without medical benefits from their employers.
It is
in their interest.
The benefit from a surgical procedure can only be determined if we assess the
patient in
the same way before and after the treatment; a point emphasized by Dr.
Zarins. While there is inconsistent use of the word ‘outcome’ in our
literature,
common sense indicates that it means what comes out of the treatment in
terms of the chosen measurement tool applied at a reasonable time after
surgery. In order to determine the effectiveness of the treatment we need
also
to know what goes into the treatment or the “ingo”. Thus the effectiveness
or
result of the arthroplasty is the difference between the outcome and the
ingo
as indicated by the same metric.
We recognize that the result of surgery is determined by three major
factors: the patient; the surgeon; and the implant or prosthesis, if one
is
used. Let us consider these determinants in reverse order.
The prosthesis. There are essentially no data indicating that
‘improvements’
in prosthetic design have a significant effect on the benefit of an
arthroplasty
to the patient. For example, two recent articles by Mileti et al
(3)
and Churchill et al (4) found no difference between ‘first’ and
‘second’ generation humeral components. In this light it is of concern
that
many tens of millions of dollars have been spent on trying to ‘improve’
the
humeral prostheses used in shoulder arthroplasty. For sure, the charges for
implants are rising faster than either the established benefit to the
patient
from their use or the funds available in the health care system to cover
the
increased charges. This is in contrast to the application of vascular
stents,
which both increased the quality of result and reduced the cost of
treating
arterial occlusive disease. Were he alive today, Codman might ask, “in
whose
interest is the design of additional and more expensive varieties of
orthopaedic prostheses?”
The surgeon. It has been determined that patients cared for by
surgeons who
performed fewer than two shoulder arthroplasties per year have more
postoperative deaths, more surgical complications, and longer lengths of
stay
than those managed by surgeons with a volume of five procedures or more
per year. In one study, Jain et al. (5) concluded, “...patients
who
have a total shoulder arthroplasty or hemiarthroplasty performed by a high
-
volume surgeon or in a high-volume hospital are more likely to have a
better
outcome.” Hammond et al. (6) found “...that the patients of
surgeons with higher average annual caseloads of total shoulder
arthroplasties and hemiarthroplasties have decreased complication rates
and
hospital length of stay compared with patients of surgeons who perform
fewer of these procedures.” “Who holds the knife” appears to have a strong
effect on the surgical result of a procedure.
The effects of inter -surgeon differences extend beyond the surgical
technique in the operating room. Harryman et al.(7)
demonstrated
that groups of patients with the same diagnosis in the practices of
different
surgeons were quite different from each another. Thus the
generalizability of the results obtained by a given surgeon treating his
or her
own patients may not be any more generalizable to all patients than the
results obtained by a particular math professor in an elite university
would be
generalizable to all college students.
The surgeon is the method.
The third factor is the patient - the complex of the
specific
surgical problem and the human being that is affected by it. William Osler
is
credited with the statement: "It is more important to know what sort of
patient has the disease than to know what sort of disease has the
patient."
Although it would seem intuitive that a patient’s physical, emotional and
social welfare would all have a powerful effect on his or her ability to
benefit
from a surgical reconstruction, there has been little research on this
important determinant of surgical effectiveness. Yet, as shown by
Rozencwaig
et al,(8) tools for this critical research, such as the SF 36
patient
self-assessment, are at hand providing a compelling and practical approach
for exploring the relationship of the patient’s perceived physical and
mental
health to the result of orthopaedic procedures.
As Dr. Zarins and we consider the validity of approaches to clinical
research in
orthopaedic surgery, we must ask, “what question are we trying to answer?”
and “will the answer we get from our study apply generally across our
specialty, or only to a relatively few patients, practices, or surgeons?”
If we
are looking for a way to determine “is prosthesis A or prosthesis B better
in
the hands of a surgeon who does nothing but this type of surgery?” we
would
want a sophisticated set of tools for controlling the variability in
patients
and their pathology as well as for documenting the function, mechanics and
radiographic anatomy before and sequentially after surgery – much as
suggested by Dr. Zarins. If we are asking “do surgeons with high volumes,
special training, or memberships in specialty societies get better
results?”, we
need a method for including as many patients and as many surgeons as
possible so that we have a statistically and externally valid sample. This
will
require the simplest and least taxing methodologies if it is to have a
chance
of succeeding. Finally, if we want to know what patients do best and what
patients fail to benefit from a procedure, we need to capture data from
the
broadest possible sample of what is really happening. It is not a question
of
subjective versus objective; validity comes from matching the tool to the
task.
Frederick A. Matsen III, M.D.
Edward V. Fehringer, M.D.
References:
(1) Codman E.A. (1934). The Shoulder: Rupture of the supraspinatus
tendon
and other lesions in or about the Subacromial Bursa. Boston, MA: Thomas
Todd. Preface
(2) Hasan, S., Leith, J., Smith, K.L., Matsen FA3rd. (2003). The
distribution of
shoulder replacements among surgeons and hospitals is significantly
different than that of hip or knee replacements. J Shoulder and Elbow
Surg.
Mar-Apr,12(2), 164-169.
(3) Mileti J, Sperling JW, Cofield RH, Harrington JR, Hoskin TL.
(2005).
Monoblock and modular total shoulder arthroplasty for osteoarthritis. J
Bone
Joint Surg Br. Apr, 87(4), 496-500.
(4) Churchill RS, Kopjar B, Fehringer EV, Boorman RS, Matsen FA 3rd.
(2005).
Humeral component modularity may not be an important factor in the
outcome of shoulder arthroplasty for glenohumeral osteoarthritis. Am J
Orthop. Apr, 34(4), 173-6.
(5) Jain N, Pietrobon R, Hocker S, Guller U, Shankar A, Higgins LD.
(2004). The
relationship between surgeon and hospital volume and outcomes for
shoulder arthroplasty. J Bone Joint Surg Am. Mar, 86-A(3), 496-505.
(6) Hammond JW, Queale WS, Kim TK, McFarland EG. (2003). Surgeon
experience and clinical and economic outcomes for shoulder arthroplasty. J
Bone Joint Surg Am. Dec, 85-A(12), 2318-24.
(7) Harryman II, D.T., Hettrich, C., Smith, K.L., Campbell, B.,
Sidles, J.A., and
Matsen III, F.A. (2003). A prospective multipractice investigation of
patients
with full thickness rotator cuff tears: The importance of co-morbidities,
surgeon, and other co-variables on self-assessed shoulder function and
health status. J Bone Joint Surg Am. 85A(4), 690-96.
(8) Rozencwaig R, van Noort A, Moskal MJ, Smith KL, Sidles JA, Matsen
FA 3rd.
(1998). The correlation of comorbidity with function of the shoulder and
health status of patients who have glenohumeral degenerative joint
disease. J
Bone Joint Surg Am. Aug, 80(8), 1146-53. |
|
Dr.Zarins responds to Drs. Anderson and Irrgang |
25 October 2005 |
|
|
Bertram Zarins, M.D., Orthopaedic surgeon MGH/Harvard Medical School, Consulting Editor for Sports Medicine, JBJS
Send letter to journal:
Re: Dr.Zarins responds to Drs. Anderson and Irrgang
bzarins{at}partners.org Bertram Zarins, M.D., et al.
|
Drs.Anderson and Irrgang make excellent points in their critique of
the editorial. Validated questionnaires are useful if
applied correctly, and are better than traditional
methods of gathering subjective information from
patients. The point of the editorial, though, was that
the pendulum has swung too far. Validated
questionnaires are being used independently as sole
measures of outcomes and are sometimes applied
inappropriately.
Using health related quality of life as the primary
outcome measure of the success of a knee operation
could lead to erroneous conclusions. Many factors
influence the quality of life, most of which have
nothing to do with the knee. To evaluate the result of
a knee operation I think we can get information that is
more meaningful if we study the quality of knee
function rather than the quality of life.
Bertram Zarins, M.D.
Consulting Editor for Sports Medicine |
|
Are Validated Questionnaires Valid? |
25 October 2005 |
|
|
Allen F. Anderson, M.D., Chairman, International Knee Documentation Committee Tennessee Orthopaedic Alliance/The Lipscomb Clinic Fdn. for Research & Education, James J. Irrgang, Ph.D., PT, ATC
Send letter to journal:
Re: Are Validated Questionnaires Valid?
AndersonAF{at}tnortho.com Allen F. Anderson, M.D., et al.
|
To The Editor:
We were concerned by the general tenor and inaccuracy of the
editorial “Are Validated Questionnaires Valid?” 2005:87:1671-2. The
editorial ostensibly sanctions a return to historical methods of outcome
assessment that primarily focused on the structure of the knee joint, not
function of the patient. Unfortunately, this unscientific approach of
evaluating outcomes based on impairment measures and reporting results
derived from knee evaluation forms that were neither valid nor comparable
often resulted in erroneous conclusions by orthopaedic researchers. The
editorial fails to acknowledge that patient reported “outcome measures are
now in vogue” because critical analysis of the orthopaedic literature
demonstrated a number of deficiencies that call into question our
fundamental basis of learning.
We disagree with the implication that validation is of questionable
value, because “there is no accepted standard of what constitutes
validation” and consequently, “it is self-proclaimed”. According to
current theory among psychometricians, validation includes the
accumulation of evidence to provide a sound scientific basis to support
interpretation of test scores for an intended purpose(1). In reality, it
is the interpretation of the test scores required by the proposed uses
that are evaluated, not the outcome instrument itself.
Having said that, the editorial makes a cogent point that use of a
“validated instrument” does not necessarily insure that the results of a
study will be valid. Validity of a study (i.e. the degree to which one
can make cause – effect conclusions) is dependent on the design of the
study, which includes evidence for the validity of the outcomes instrument
and the procedures that are used to implement the study. Researchers
should refrain from stating that an instrument is “validated”, implying
that it is validated for all uses. When patient-reported outcome
instruments are used in more than one way, each interpretation/use
requires validity evidence. Consequently, the comments regarding the SF-
36, WOMAC and KOOS are appropriate, as there is little validity evidence
to support the interpretation of these instruments for a population of
patients following ACL reconstruction.
The statement that construct validity is determined by correlating
subject’s answers to questions with objective measurements is an over
simplification. Construct validity is the degree that test scores conform
to hypothetical relationships to other variables, not just objective
measures(2). Testing the hypothesis that scores of an outcomes instrument
would be related to the SF-36 physical function score, but not related to
the mental component score provides some evidence of construct validity.
Some researchers refer to this as convergent and divergent validity
evidence. Additional evidence of construct validity may be provided by
demonstrating hypothesized relationships with other measures of knee
function (some would call this criterion-related validity) as well as
demonstrated hypothetical relationships between groups known or
hypothesized to have different levels of function. For example, it may be
hypothesized that younger subjects would have higher scores than older
subjects, subjects with normal knees would have higher scores than those
with a history of knee problems, or, patients would have higher scores
after ACL reconstruction than patients with chronic knee conditions such
as osteoarthritis. Construct validity of IKDC Subjective Knee Form was
demonstrated by the degree that subject test scores conformed to these and
other hypothesized relationships(3,4,5).
We also disagree with the comments regarding the IKDC Subjective Knee
Form. The editorial stated that because the IKDC form is generic for knee
problems and not specific for sports and instability, that it can have
little meaning for evaluating patients with ACL injuries. A major
objective in the development of the IKDC Subjective Knee Form was to
create a region specific, rather than a disease specific, form that was
appropriate to evaluate patients with a variety of knee impairments
including ligament and meniscal injuries, patellofemoral pain and
osteoarthritis, because function of the knee is dependent on more than
just one structure (i.e. the ACL). Outcome instruments that are disease
specific may not be appropriate for evaluation of outcomes of treatment
for ACL tears when other conditions occur concomitantly. Development of a
single form that is valid for patient’s with a variety of conditions
affecting the knee simplifies data collection because the same form may be
used for all patients. Item response theory demonstrated that the IKDC
Subjective Knee form functioned equally well for patients with ACL
injuries and other conditions(3). The alternative would be to use
multiple forms, like Spindler, et al,(8) to document the outcomes of patients
with traumatic arthritis and other conditions that frequently occur in the
ACL deficient knee.
As evidence to support the contention that the IKDC Subjective Knee
Form has little meaning for evaluating patients with ACL injuries, the
editorial stated that a patient who had a torn ACL with a knee that is
functionally unstable can receive 95 of 100 points. On the contrary, our
data does not support that contention. The mean IKDC Subjective Knee Form
score for patients with an ACL deficient knee was 47.6 at baseline and
80.1 at final followup(5). The mean IKDC score for males from 18 – 24
years of age with normal knees is 89.1(4). There were also few ceiling
effects which are common in general health measures(3). Therefore, it is
highly unlikely that a patient with an unstable ACL deficient knee would
score 95 on the IKDC Subjective Knee form. In addition, the IKDC
Subjective Knee score has been shown to be significantly correlated with
patient satisfaction after ACL reconstruction(6).
Historic methods of orthopaedic evaluation were primarily based on
impairment measures such as range of motion, strength and laxity.
Although we agree with the editorial that both subjective and objective
outcomes are necessary for complete evaluation of results, it is important
to understand the relationship between impairment and resulting activity
limitations and participation restrictions is not direct. For example,
several authors have demonstrated that there is no relationship between KT
-1000 measurements and patient-reported activity and participation(6,7).
We believe that activity and participation are of most concern to the
patient. Therefore, health related quality of life should be the primary
outcome measure. The secondary, objective outcome measures complete the
picture by evaluating effectiveness of treatment in reducing impairment.
Recent analysis of the orthopaedic literature has demonstrated
deficiencies in our past methods of assessment. Despite the negativity of
this editorial, orthopaedic surgeons should continue to improve
methodological quality by embracing valid clinical outcomes research that
includes patient-reported outcome measures, an evolution of assessment
that is scientifically rigorous, allowing critical evaluation of results
and refinement of knee surgery.
Allen F. Anderson, M.D.,
Tennessee Orthopaedic Alliance/The Lipscomb Clinic,
The Lipscomb Clinic Foundation for Research and Education,
Nashville, Tennessee, U.S.A.
James J. Irrgang PhD PT ATC,
Director of Clinical Research,
Department of Orthopaedic Surgery,
University of Pittsburgh School of Medicine
REFERENCES:
1) American Educational Research Association, American Psychological
Association; National Council on Measurement in Education: Standards for
Educational and Psychological Testing. Published by American Educational
Research Association, Wash DC 1999.
2) Steiner DL, Norman GR: Health Measurement Scales: A Practical
Guide to their Development and Use 2nd Ed. Oxford University Press,
Oxford, 1995.
3) Irrgang JJ. Anderson AF. Boland AL. Harner CD. Kurosaka M. Neyret
P. Richmond JC. Shelborne KD. Development and validation of the
International Knee Documentation Committee Subjective Knee Form.
Am.J.Sports Med. 2001; 29: 600-613.
4) Anderson AF. Irrgang JJ. Kocher M Mann B, Harrast J., Members of
the IKDC. International Knee Documentation Committee (IKDC) Subjective
Knee Form: Data from a nationally representative sample. Am.J.Sports Med.
(in press)
5) Irrgang, J. J., Anderson, A. F., Boland, A. L., Harner, C. D.,
Neyret, P., Richmond, J. C., Shelborne, K. D., and International Knee
Documentation Committee. Responsiveness of the International Knee
Documentation Committee Subjective Knee Form. American Journal of Sports
Medicine. (In revision)
6) Kocher MS. Steadman JR. Briggs KK. Sterett WI. Hawkins RJ.
Relationships between objective assessment of ligament stability and
subjective assessment of symptoms and function after anterior cruciate
ligament reconstruction. American Journal of Sports Medicine. 32(3):629-
34, 2004 Apr-May.
7) Snyder-Mackler L, Fitzgerald GK, Bartolozzi AR, Ciccotti MD: The
relationship between passive joint laxity and functional outcome after
anterior cruciate ligament injury. Am J Sp Med 25: 191-195, 1997.
8) Spindler KP, MD, Waren TA, NP, ATC, Callison, Jr. JC, et al. Clinical outcome at a minimum of five years after reconstruction of the anterior cruciate ligament. J Bone Joint Surg. 2005;87-A, No. 8, pp. 1673-1679. |
|
Are Validated Questionnaires Valid? |
29 September 2005 |
|
|
Bruce D. Beynnon, Director of Research The University of Vermont, Ewa Roos, Stefan Lohmander, and Robert J Johnson
Send letter to journal:
Re: Are Validated Questionnaires Valid?
bruce.beynnon{at}uvm.edu Bruce D. Beynnon, et al.
|
To the Editor:
The focus of Dr. Zarins recent editorial was on the use of different types of outcome measures to assess
the treatment of anterior cruciate ligament injuries.
He appropriately outlined the procedure which should be
followed to establish that a patient-oriented outcome measure has been
validated. There is no doubt that this is critical for outcomes that
measure a subject’s perspective of an injury and subsequent treatment.
Dr. Zarins made a very important point when he highlighted that the
validation of a questionnaire, or an objective test, should involve
testing its test-retest reproducibility, responsiveness to detect
clinically important changes, face validity, content validity, and
construct validity. We also agree with Dr. Zarins’ perspective-- all outcome measures should be
validated for the specific application for which they are intended.
Dr. Zarins also stated that the Knee Injury and Osteoarthritis Outcome
Score (KOOS) “is designed for osteoarthritis and has not been validated
for the study of anterior cruciate ligament injuries”. This is simply not
true. The KOOS has undergone extensive validation for the assessment of
anterior cruciate ligament injuries(1,2) This work has included
evaluating its test-retest reproducibility, responsiveness to detect
clinically important changes, face validity, content validity, and
construct validity. In addition, it has been validated for orthopaedic
interventions such as meniscectomy.(3) The KOOS meets the basic validity
criteria (outlined above) to evaluate injury and treatment of anterior
cruciate ligament tears, and this research has been published for some
time.(1,2,3) The KOOS is a valid, reliable, and responsive self-
administered instrument that can be used for short- and long-term follow-
up of different types of knee injuries.
<
We take this opportunity to congratulate Dr. Spindler and co-authors
for their interesting study on long-term outcomes after ACL injury.(4)
Their results highlight the importance of using several complementary and
validated outcome measures to evaluate the patient-relevant aspects of
this complex injury. The clinical, patient relevant, endpoint serves as
our gold standard for the pharmacological, surgical or other form of
medical treatment.
Sincerely,
Bruce D. Beynnon, PhD,
Director of Research,
The University of Vermont,
Burlington, VT, USA
Ewa Roos, PT, PhD,
Lund University Hospital,
Lund, Sweden
Stefan Lohmander, MD, PhD,
Lund University Hospital,
Lund, Sweden
Robert J. Johnson, MD,
The University of Vermont,
Burlington, VT, USA
References:
1) Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee injury
and osteoarthritis outcome score (KOOS) – Development of a self-
administered outcome measure. J Orthopaedic and Sports Physical Therapy.
1998;78(2):88-96.
2) Roos EM, Lohmander LS. The knee injury and osteoarthritis outcome
score (KOOS): from joint injury to osteoarthritis. Health and Quality of
Life Outcomes. 2003;1:64.
3) Roos EM, Roos HP, Ekdahl C, Lohmander LS. Knee injury and
Osteoarthritis Outcome Score (KOOS) – Validation of a Swedish version.
Scand J Med Sci Sports 1998;8:439-48.
4) Spindler KP, Warren TA, Callison JC Jr, Secic M, Fleisch SB,
Wright RW. Clinical outcome at a minimum of five years after
reconstruction of the anterior cruciate ligament. J Bone Joint Surg Am.
2005;87:1673-1679. |
|
Are Validated Questionnaires Valid? |
21 September 2005 |
|
|
James G. Wright, M.D. Associate Editor JBJS
Send letter to journal:
Re: Are Validated Questionnaires Valid?
james.wright{at}sickkids.ca James G. Wright, M.D.
|
To the Editor:
I write to disagree with Dr. Zarin’s recent editorial [Zarins B.: Are
Validated Questionnaires Valid? J Bone Joint Surg Am. 87:1671-1672, 2005].
Dr. Zarins concludes that “subjective data are insufficient for evaluating
the results of an operation” and “subjective data, no matter how valid,
should not stand alone”.
The essence of Dr. Zarins’ argument is that subjective measurements
are sometimes used inappropriately. His main example is that measures
developed in one context are sometimes being used inappropriately in
another. He also states that finding a relationship between independent
variables does not mean that one caused the other.
Neither of these examples is convincing or relevant because exactly
the same concerns apply to objective measurements. The choice is simple--in evaluating a surgical procedure, if I have to choose between an
objective measure, and a subjective measure which validly addresses
patient clinical concerns, I know which measurement the patient would ask
me to choose.
Yours truly,
James G. Wright, MD, MPH, FRCSC |
|